Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Africa: Access Planning for Ebola Medicines Moves Ahead During Clinical Trials

[UNITAID] Unitaid welcomes Gilead's announcement of royalty-free voluntary licensing agreements with Dr. Reddy's Laboratories, Eva Pharma and Ferozsons Laboratories. The agreements lay the groundwork for wider access to obeldesivir, an investigational antiviral being studied to prevent Ebola Bundibugyo virus disease (BVD). If clinical evidence supports its use and regulators approve it, the three…

We haven't written up this one. AllAfrica Health has the full story — the link below goes straight to it.

Read the original at allafrica.com →

More in Health & Medicine

More from Wednesday 18 November →